Sun Pharma Advanced Research Company Limited Cash Flow Conversion Efficiency

Latest as of September 2025: 0.336x

Sun Pharma Advanced Research Company Limited cash flow conversion efficiency. Based on the latest financial reports, Sun Pharma Advanced Research Company Limited (SPARC) has a cash flow conversion efficiency ratio of 0.336x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-1.16 Billion ≈ $-12.53 Million USD) by net assets (Rs-3.45 Billion ≈ $-37.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Sun Pharma Advanced Research Company Limited (2007–2025)

Cash flow conversion efficiency of Sun Pharma Advanced Research Company Limited from 2007 to 2025. This chart illustrates how Sun Pharma Advanced Research Company Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SPARC stock price for real-time trading data and today's change.

Sun Pharma Advanced Research Company Limited Cash Flow Conversion Ratio Explained

Sun Pharma Advanced Research Company Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Sun Pharma Advanced Research Company Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sun Pharma Advanced Research Company Limited ranked by their cash flow conversion efficiency. Also see Sun Pharma Advanced Research Company Lim (SPARC) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
SurModics Inc NASDAQ:SRDX	0.013x
Suzhou Longway Electronic Machinery Co. Ltd. A SHE:301202	N/A
Just Dial Limited NSE:JUSTDIAL	0.023x
uPI Semiconductor Corp TW:6719	0.020x
MarineMax Inc NYSE:HZO	0.018x
Shandong Realcan Pharmaceutical Co Ltd SHE:002589	-0.003x
Sichuan Discovery Dream Science & Technology Co.Ltd SHE:301213	N/A
BOROSIL RENEWABLES LIMITED NSE:BORORENEW	0.090x

Annual Cash Flow Conversion Efficiency for Sun Pharma Advanced Research Company Limited (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sun Pharma Advanced Research Company Limited from 2007 to 2025. Review SPARC FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs-2.17 Billion ≈ $-23.46 Million	Rs-3.60 Billion ≈ $-38.96 Million	1.661x	+148.66%
2024-03-31	Rs1.26 Billion ≈ $13.60 Million	Rs-4.29 Billion ≈ $-46.42 Million	-3.413x	-2431.86%
2023-03-31	Rs5.13 Billion ≈ $55.45 Million	Rs-691.20 Million ≈ $-7.48 Million	-0.135x	+97.98%
2022-03-31	Rs312.26 Million ≈ $3.38 Million	Rs-2.08 Billion ≈ $-22.52 Million	-6.669x	-838.67%
2021-03-31	Rs-1.68 Billion ≈ $-18.20 Million	Rs-1.52 Billion ≈ $-16.43 Million	0.903x	-92.02%
2020-03-31	Rs-186.38 Million ≈ $-2.02 Million	Rs-2.11 Billion ≈ $-22.80 Million	11.310x	+2048.94%
2019-03-31	Rs2.96 Billion ≈ $32.04 Million	Rs-1.72 Billion ≈ $-18.59 Million	-0.580x	+41.35%
2018-03-31	Rs1.85 Billion ≈ $19.98 Million	Rs-1.83 Billion ≈ $-19.77 Million	-0.989x	-23.37%
2017-03-31	Rs1.60 Billion ≈ $17.27 Million	Rs-1.28 Billion ≈ $-13.85 Million	-0.802x	+45.76%
2016-03-31	Rs299.03 Million ≈ $3.23 Million	Rs-442.12 Million ≈ $-4.78 Million	-1.479x	-272.84%
2015-03-31	Rs997.99 Million ≈ $10.79 Million	Rs-395.76 Million ≈ $-4.28 Million	-0.397x	-249.72%
2014-03-31	Rs1.39 Billion ≈ $15.06 Million	Rs368.95 Million ≈ $3.99 Million	0.265x	+130.12%
2013-03-31	Rs1.08 Billion ≈ $11.73 Million	Rs-953.44 Million ≈ $-10.31 Million	-0.879x	-184.34%
2012-03-31	Rs-666.09 Million ≈ $-7.20 Million	Rs-694.49 Million ≈ $-7.51 Million	1.043x	+134.07%
2011-03-31	Rs56.23 Million ≈ $608.16K	Rs25.05 Million ≈ $270.90K	0.445x	-50.20%
2010-03-31	Rs141.24 Million ≈ $1.53 Million	Rs126.34 Million ≈ $1.37 Million	0.895x	+25.38%
2009-03-31	Rs356.78 Million ≈ $3.86 Million	Rs254.54 Million ≈ $2.75 Million	0.713x	+256.80%
2008-03-31	Rs448.18 Million ≈ $4.85 Million	Rs-203.92 Million ≈ $-2.21 Million	-0.455x	-54787.50%
2007-03-31	Rs497.01 Million ≈ $5.37 Million	Rs-412.00K ≈ $-4.46K	-0.001x	--

About Sun Pharma Advanced Research Company Limited

NSE:SPARC India Drug Manufacturers - Specialty & Generic

Market Cap

$614.49 Million

Rs56.82 Billion INR

Market Cap Rank

#10883 Global

#543 in India

Share Price

Rs175.09

Change (1 day)

-0.78%

52-Week Range

Rs108.71 - Rs277.57

All Time High

Rs519.35